These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 7529259)

  • 1. Autoregulatory circuits in myeloma. Tumor cell cytotoxicity mediated by soluble CD16.
    Hoover RG; Lary C; Page R; Travis P; Owens R; Flick J; Kornbluth J; Barlogie B
    J Clin Invest; 1995 Jan; 95(1):241-7. PubMed ID: 7529259
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The CD56 adhesion molecule is the major determinant for detecting non-major histocompatibility complex-restricted cytotoxic mononuclear cells from the intestinal lamina propria.
    Van Tol EA; Verspaget HW; Peña AS; Kraemer CV; Lamers CB
    Eur J Immunol; 1992 Jan; 22(1):23-9. PubMed ID: 1370415
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Growth inhibition of RPMI 8226 human myeloma cells by peripheral blood lymphocytes.
    Amano T; Katagiri S; Tominaga N; Oritani K; Tamaki T; Kanayama Y; Yonezawa T; Tarui S
    Acta Haematol; 1992; 87(1-2):37-44. PubMed ID: 1350158
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Minimally invasive versus open Roux-en-Y gastric bypass: effect on immune effector cells.
    Whitson BA; D'Cunha J; Hoang CD; Wu B; Ikramuddin S; Buchwald H; Panoskaltsis-Mortari A; Kratzke RA; Miller JS; Maddaus MA
    Surg Obes Relat Dis; 2009; 5(2):181-93. PubMed ID: 18996756
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An increase in the absolute count of CD56dimCD16+CD69+ NK cells in the peripheral blood is associated with a poorer IVF treatment and pregnancy outcome.
    Thum MY; Bhaskaran S; Abdalla HI; Ford B; Sumar N; Shehata H; Bansal AS
    Hum Reprod; 2004 Oct; 19(10):2395-400. PubMed ID: 15319390
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of CD16 (Fc receptor III) and interleukin-2 in the reactivation of natural killer cells after inhibitory target cell contact.
    Heiskala M; Ståhls A; Seppälä I; Timonen T
    Nat Immun Cell Growth Regul; 1991; 10(5):265-77. PubMed ID: 1836835
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of cytolytic activity in CD3- and CD3+ killer cell clones by monoclonal antibodies (anti-CD16, anti-CD2, anti-CD3) depends on subclass specificity of target cell IgG-FcR.
    van de Griend RJ; Bolhuis RL; Stoter G; Roozemond RC
    J Immunol; 1987 May; 138(10):3137-44. PubMed ID: 2952709
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Concomitant mobilization of plasma cells and hematopoietic progenitors into peripheral blood of patients with multiple myeloma.
    Lemoli RM; Cavo M; Fortuna A
    J Hematother; 1996 Aug; 5(4):339-49. PubMed ID: 8877709
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The human natural killer cell receptor for major histocompatibility complex class I molecules. Surface modulation of p58 molecules and their linkage to CD3 zeta chain, Fc epsilon RI gamma chain and the p56lck kinase.
    Bottino C; Vitale M; Olcese L; Sivori S; Morelli L; Augugliaro R; Ciccone E; Moretta L; Moretta A
    Eur J Immunol; 1994 Oct; 24(10):2527-34. PubMed ID: 7523145
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Redistribution of natural killer (NK) cell frequency and NK cytotoxic activity in primary IgA nephropathy.
    Antonaci S; Polignano A; Ottolenghi A; Tortorella C; Schena FP
    Cytobios; 1992; 69(276):27-34. PubMed ID: 1374697
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Involvement of FcR+ T cells and of IgG-BF in the control of myeloma cells.
    Teillaud JL; Brunati S; Elmalek M; Astier A; Nicaise P; Moncuit J; Mathiot C; Job-Deslandre C; Fridman WH
    Mol Immunol; 1990 Dec; 27(12):1209-17. PubMed ID: 2148806
    [No Abstract]   [Full Text] [Related]  

  • 12. CD4+CD25+FOXP3+ T regulatory cells reconstitute and accumulate in the bone marrow of patients with multiple myeloma following allogeneic stem cell transplantation.
    Atanackovic D; Cao Y; Luetkens T; Panse J; Faltz C; Arfsten J; Bartels K; Wolschke C; Eiermann T; Zander AR; Fehse B; Bokemeyer C; Kroger N
    Haematologica; 2008 Mar; 93(3):423-30. PubMed ID: 18287134
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of production of soluble Fc gamma receptors type III in normal and pathological conditions.
    Moldovan I; Galon J; Maridonneau-Parini I; Roman Roman S; Mathiot C; Fridman WH; Sautès-Fridman C
    Immunol Lett; 1999 May; 68(1):125-34. PubMed ID: 10397167
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro responsiveness to interleukins and theophylline of CD16+, CD56- natural killer cells in a patient with chronic granular lymphocyte disorder.
    Bayle C; Vitté-Mony I; Lang P; Pico J; Hercend T; Bertoglio J
    Leukemia; 1992 May; 6(5):470-6. PubMed ID: 1375700
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation between soluble serum CD16 (sCD16) levels and disease stage in patients with multiple myeloma.
    Mathiot C; Teillaud JL; Elmalek M; Mosseri V; Euller-Ziegler L; Daragon A; Grosbois B; Michaux JL; Facon T; Bernard JF
    J Clin Immunol; 1993 Jan; 13(1):41-8. PubMed ID: 8445043
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Morphological, phenotypic and functional characteristics of a pure population of CD56+ CD16- CD3- large granular lymphocytes generated from human duodenal mucosa.
    Pang G; Buret A; Batey RT; Chen QY; Couch L; Cripps A; Clancy R
    Immunology; 1993 Jul; 79(3):498-505. PubMed ID: 7691728
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of the Fc mu receptor on human natural killer cells. Interaction with its physiologic ligand, human normal IgM, specificity of binding, and functional effects.
    Pricop L; Rabinowich H; Morel PA; Sulica A; Whiteside TL; Herberman RB
    J Immunol; 1993 Sep; 151(6):3018-29. PubMed ID: 7690792
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cord blood CD16+56- cells with low lytic activity are possible precursors of mature natural killer cells.
    Gaddy J; Broxmeyer HE
    Cell Immunol; 1997 Sep; 180(2):132-42. PubMed ID: 9341743
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chagasic patients with indeterminate clinical form of the disease have high frequencies of circulating CD3+CD16-CD56+ natural killer T cells and CD4+CD25High regulatory T lymphocytes.
    Vitelli-Avelar DM; Sathler-Avelar R; Dias JC; Pascoal VP; Teixeira-Carvalho A; Lage PS; Elói-Santos SM; Corrêa-Oliveira R; Martins-Filho OA
    Scand J Immunol; 2005 Sep; 62(3):297-308. PubMed ID: 16179017
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lymphoproliferative disorder of granular lymphocytes: nine cases including one with features of CD56 (NKH1)-positive aggressive natural killer cell lymphoma.
    Nichols GE; Normansell DE; Williams ME
    Mod Pathol; 1994 Oct; 7(8):819-24. PubMed ID: 7530849
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.